Utilization of Dabigatran for Atrial Fibrillation at 3 Tertiary Care Centres

Canadian Journal of Hospital Pharmacy- Canada

doi 10.4212/cjhp.v68i5.1483

Full Text

Abstract

Available in

Categories

Date

October 7, 2015

Authors

Aleesa A Carter

Publisher

Canadian Society of Hospital Pharmacists (CSHP)

Related search

Dabigatran Challenges Warfarin's Superiority for Stroke Prevention in Atrial Fibrillation

Cardiovascular Medicine

Specialized Nursing

English

How to Use Dabigatran in Patients With Atrial Fibrillation

Rational Pharmacotherapy in Cardiology

Cardiovascular Medicine

English

Use of Dabigatran for Periprocedural Anticoagulation in Patients Undergoing Catheter Ablation for Atrial Fibrillation

Circulation: Arrhythmia and Electrophysiology

Cardiovascular Medicine

English

Major Bleeding With Dabigatran and Rivaroxaban in Patients With Atrial Fibrillation

Clinical and Applied Thrombosis/Hemostasis

English

Cost-Effectiveness of Cardiac Radiosurgery for Atrial Fibrillation: Implications for Reducing Health Care Morbidity, Utilization, and Costs

English

New Therapeutic Strategies for Atrial Fibrillation: 3. Catheter Ablation of Atrial Fibrillation: Its Indication and Problems

Internal Medicine

Internal Medicine

English

Dabigatran Versus Warfarin in Patients With Atrial Fibrillation: An Analysis of Patients Undergoing Cardioversion

Cardiovascular Medicine

English

Pharmacoeconomic Analysis of Dabigatran in Patients With Atrial Fibrillation: Comparison With Rivaroxaban or Apixaban

Value in Health

Occupational Health

English

Risk Factors and Prevention of Dabigatran-Related Gastrointestinal Bleeding in Patients With Atrial Fibrillation

Journal of Arrhythmia

Cardiovascular Medicine

English